Editorial
Published on 03 Feb 2015
The Treatment of Metastatic Non-Small Cell Lung Cancer in a New Era of Personalized Medicine
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2015.00020
- 6,305 views
- 2 citations
- Frontiers in Oncology
- Thoracic Oncology
- Articles
Type at least 3 characters
1,970 articles
articles
Original Research
Published on 28 Jan 2015
Prospective Validation Obtained in a Similar Group of Patients and with Similar High Throughput Biological Tests Failed to Confirm Signatures for Prediction of Response to Chemotherapy and Survival in Advanced NSCLC: A Prospective Study from the European Lung Cancer Working Party
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2014.00386
- 5,739 views
- 10 citations
Original Research
Published on 19 Dec 2014
Fanconi Anemia Repair Pathway Dysfunction, a Potential Therapeutic Target in Lung Cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2014.00368
- 8,540 views
- 32 citations
Review
Published on 09 Dec 2014
Promising Targets and Current Clinical Trials in Metastatic Squamous Cell Lung Cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2014.00320
- 7,156 views
- 5 citations
Clinical Case Study
Published on 08 Dec 2014
EGFR Mutation Positive Stage IV Non-Small-Cell Lung Cancer: Treatment Beyond Progression
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2014.00350
- 35,133 views
- 14 citations
Mini Review
Published on 25 Nov 2014
Promising Targets and Current Clinical Trials in Metastatic Non-Squamous NSCLC
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2014.00329
- 10,033 views
- 35 citations
General Commentary
Published on 10 Nov 2014
Good Syndrome, Bad Problem
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2014.00307
- 12,846 views
- 24 citations
Perspective
Published on 05 Nov 2014
Clinical Utility of Circulating Tumor Cells in ALK-Positive Non-Small-Cell Lung Cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2014.00281
- 8,134 views
- 26 citations
Review
Published on 22 Oct 2014
Immunotherapy for Lung Cancer: Has it Finally Arrived?
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2014.00288
- 15,203 views
- 33 citations
Clinical Trial
Published on 14 Oct 2014
A Multicenter Pilot Study Examining the Role of Circulating Tumor Cells as a Blood-Based Tumor Marker in Patients with Extensive Small-Cell Lung Cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2014.00271
- 7,143 views
- 31 citations
Mini Review
Published on 13 Oct 2014
Role of Radiotherapy in Metastatic Non-Small Cell Lung Cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2014.00229
- 10,131 views
- 13 citations
Mini Review
Published on 29 Sep 2014
Treatment Algorithms for Patients with Metastatic Non-Small Cell, Non-Squamous Lung Cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2014.00256
- 12,401 views
- 20 citations
Original Research
Published on 29 Sep 2014
Hidden Treasures in “Ancient” Microarrays: Gene-Expression Portrays Biology and Potential Resistance Pathways of Major Lung Cancer Subtypes and Normal Tissue
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2014.00251
- 8,683 views
- 18 citations
Mini Review
Published on 22 Sep 2014
Economic Impact of Tissue Testing and Treatments of Metastatic NSCLC in the Era of Personalized Medicine
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2014.00258
- 5,798 views
- 5 citations
Mini Review
Published on 22 Sep 2014
Optimizing Tissue Sampling for the Diagnosis, Subtyping, and Molecular Analysis of Lung Cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2014.00253
- 13,174 views
- 40 citations
Review
Published on 16 Sep 2014
Management of Common Toxicities in Metastatic NSCLC Related to Anti-Lung Cancer Therapies with EGFR–TKIs
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2014.00238
- 16,112 views
- 69 citations
Mini Review
Published on 15 Sep 2014
The Management of Brain Metastases in Non-Small Cell Lung Cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2014.00248
- 59,568 views
- 72 citations
Mini Review
Published on 15 Sep 2014
Review of EGFR TKIs in Metastatic NSCLC, Including Ongoing Trials
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2014.00244
- 14,695 views
- 63 citations
Mini Review
Published on 04 Sep 2014
Clinical Applications of Circulating Tumor Cells in Lung Cancer Patients by CellSearch System
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2014.00242
- 19,283 views
- 75 citations
Mini Review
Published on 27 Aug 2014
Trials to Overcome Drug Resistance to EGFR and ALK Targeted Therapies – Past, Present, and Future
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2014.00233
- 9,644 views
- 18 citations
Mini Review
Published on 19 Aug 2014
Maintenance Therapies for Non-Small Cell Lung Cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2014.00213
- 7,508 views
- 16 citations
Mini Review
Published on 11 Aug 2014
Biomarkers That Currently Affect Clinical Practice in Lung Cancer: EGFR, ALK, MET, ROS-1, and KRAS
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2014.00204
- 52,375 views
- 172 citations
Mini Review
Published on 30 Jul 2014
Collaborative Care in NSCLC; the Role of Early Palliative Care
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2014.00192
- 6,023 views
- 8 citations
Mini Review
Published on 23 Jul 2014
Drug Resistance to Molecular Targeted Therapy and Its Consequences for Treatment Decisions in Non-Small-Cell Lung Cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2014.00190
- 8,366 views
- 60 citations